Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J

Slides:

Advertisements

Similar presentations

Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing.

Advertisements

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients Lily Chen, BA, Feng Gao, MD, PhD, MPH,

Analysis of US dermatology physician assistant density

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH

A girl with a solitary red bulla

Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients Patrizia Weber, MD, S. Morteza Seyed Jafari,

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Psoriasis is associated with lipid abnormalities at the onset of skin disease Lotus Mallbris, MD, PhD, Fredrik Granath, PhD, Anders Hamsten, MD, PhD,

Psoriasis: Latitude does make a difference

Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients Lucy Y. Liu, BA, Brittany.

Baldness reversed by chemotherapy

Ahmad Al Aboud, MD, Melissa Abrams, MD, Anthony J. Mancini, MD

Efficacy of simvastatin in plaque psoriasis: A pilot study

Hypertrichosis around a leg ulcer being treated with prostaglandin E1 ointment Tetsuya Honda, MD, PhD, Satoshi Koreeda, MD, PhD, Yoshiki Miyachi, MD,

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD

Sarah Sung, MD, Alexa B. Kimball, MD, MPH

María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD

Surveillance and assessment of occupational dermatitis using Rhode Island workers' compensation data 1998 to 2002 Irwin B. Horwitz, PhD, Brian P. McCall,

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

JAK inhibitors in dermatology: The promise of a new drug class

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD

David T. Pompei, Pharm D, Kameron S. Rezzadeh, BS, Kate V

Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry David Fiorentino, MD, PhD, Vincent Ho, MD, Mark.

The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis Alan Menter, MD, Jennifer C. Cather, MD, Diane.

Assessing adherence with phototherapy protocols

Khanh P. Thieu, BS, Harley A. Haynes, MD

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial William Tuong,

Pharmacy costs of specialty medications for plaque psoriasis in the United States Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

Smoking and risk of psoriasis: A nationwide cohort study

Applying for dermatology residency is difficult and expensive

Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection Alberto Conde-Taboada, MD, Javier Pedraz Muñoz, MD, Lucía.

Characterization of disease burden, comorbidities, and treatment use in a large, US- based cohort: Results from the Corrona Psoriasis Registry Bruce Strober,

Plasma β-endorphin levels in frequent and infrequent tanners before and after ultraviolet and non-ultraviolet stimuli Mandeep Kaur, MD, Anthony Liguori,

Chauncey C. Caldwell, MD, Sami K. Saikaly, MD, Robert P

Reply to: “A note on normality”

Google search trends for tanning salons: Temporal patterns indicate peak interest in mid spring Derek D. Reed, PhD, BCBA-D Journal of the American Academy.

Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis Eric Sorenson, AB, Ethan Levin, MD, John Koo, MD, Timothy.

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

Treatment of psoriasis vulgaris using low-dose naltrexone

SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss Elise A. Olsen, MD, Douglas Canfield, BS Journal.

Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks

Infectious rash after riding elephants

Lip edema Journal of the American Academy of Dermatology

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions Herbert C. Chiang, MD,

Granulocyte and monocyte adsorption apheresis for leg ulcers in a patient with rheumatoid arthritis Takuro Kanekura, MD, PhD, Yuji Mochitomi, MD, Shizuyo.

Hugh Gloster, MD, Chesahna Kindred, MBA

Seasonal patterns in alopecia areata, totalis, and universalis

Appearance of lentigines in psoriasis patients treated with apremilast

Medicaid acceptance among pediatric dermatologists

Guidelines of care for the management of psoriasis and psoriatic arthritis Alan Menter, MD, Neil J. Korman, MD, PhD, Craig A. Elmets, MD, Steven R. Feldman,

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Modification of the nail psoriasis severity index

Tofacitinib therapy for children with severe alopecia areata

Alice Gottlieb, MD, PhD, Neil J. Korman, MD, PhD, Kenneth B

Gordon W. Jung, MD, Patricia T. Ting, MSc, MD, Thomas G

Simple onycholysis: A diagnosis of exclusion

Jose Fernández-Vozmediano, PhD, Jose Armario-Hita, MD

Michelle A. Pipitone, MD, Brian Adams, MD, MPH, Anita Sheth, MD, T

Etanercept therapy in two patients with psoriasis and concomitant hepatitis C Clara De Simone, MD, Andrea Paradisi, MD, Rodolfo Capizzi, MD, Angelo Carbone,

A simple algorithm for evaluating dermatologic disease in critically ill patients: A study based on retrospective review of medical intensive care unit.

Comparative effectiveness of biologic agents for the treatment of psoriasis in a real- world setting: Results from a large, prospective, observational.

Eyebrow transplantation: Alternative body sites as a donor source

Gaps in pain management in dermatology: A needs assessment from Canada

Numerous hyperpigmented macules of the oral mucosa

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

“Boot foot” with pseudomonas colonization

Anastasia O. Kurta, DO, Daisy Dai, PhD, Eric S

Stuart M. Goldsmith, MD, Armand B. Cognetta, MD

Brodalumab in the treatment of moderate to severe psoriasis in patients when previous anti-interleukin 17A therapies have failed Grace Kimmel, MD, Margot.

Presentation transcript:

Psoriasis treatment patterns: Results of a cross-sectional survey of dermatologists Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J. Lobosco, MA, Kathleen M. Fox, PhD, Seth R. Stevens, Mark Lebwohl, MD Journal of the American Academy of Dermatology Volume 58, Issue 6, Pages 964-969 (June 2008) DOI: 10.1016/j.jaad.2008.02.048 Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Data collection methodology. Journal of the American Academy of Dermatology 2008 58, 964-969DOI: (10.1016/j.jaad.2008.02.048) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

Fig 2 Dermatologists' reported (N = 90) prescribing patterns for patients with psoriasis. Journal of the American Academy of Dermatology 2008 58, 964-969DOI: (10.1016/j.jaad.2008.02.048) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

Fig 3 Drug therapy patterns by body surface area (BSA) affected (>10%) among patients with psoriasis as documented in patient records. Journal of the American Academy of Dermatology 2008 58, 964-969DOI: (10.1016/j.jaad.2008.02.048) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions